Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Systemic lupus erythematosusThe Lancet (British edition), 2024-05, Vol.403 (10441), p.2326-2338 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00398-2 ;PMID: 38642569Full text available |
2 |
Material Type: Article
|
![]() |
Rethinking health policy: life expectancy and mortality in an era of polycrisisThe Lancet (British edition), 2024-05, Vol.403 (10440), p.1956-1958 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00754-2 ;PMID: 38762310Full text available |
3 |
Material Type: Article
|
![]() |
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021The Lancet (British edition), 2024-05, Vol.403 (10440), p.2204-2256 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00685-8 ;PMID: 38762325Full text available |
4 |
Material Type: Article
|
![]() |
Global Burden of Disease Study 2021 estimates: implications for health policy and researchThe Lancet (British edition), 2024-05, Vol.403 (10440), p.1958-1959 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00812-2 ;PMID: 38642567Full text available |
5 |
Material Type: Article
|
![]() |
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet (British edition), 2024-05, Vol.403 (10440), p.2133-2161 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00757-8 ;PMID: 38642570Digital Resources/Online E-Resources |
6 |
Material Type: Article
|
![]() |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet (British edition), 2024-05, Vol.403 (10440), p.2100-2132 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2024 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00367-2 ;PMID: 38582094Digital Resources/Online E-Resources |
7 |
Material Type: Article
|
![]() |
AI-enabled opportunistic medical scan interpretationThe Lancet (British edition), 2024-05, Vol.403 (10439), p.1842-1842 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00924-3 ;PMID: 38735291Full text available |
8 |
Material Type: Article
|
![]() |
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trialThe Lancet (British edition), 2024-05, Vol.403 (10439), p.1855-1865 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00282-4 ;PMID: 38604212Full text available |
9 |
Material Type: Article
|
![]() |
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trialThe Lancet (British edition), 2024-05, Vol.403 (10438), p.1753-1765 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00413-6 ;PMID: 38604213Full text available |
10 |
Material Type: Article
|
![]() |
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trialThe Lancet (British edition), 2024-05, Vol.403 (10438), p.1749-1749 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00354-4 ;PMID: 38704166Full text available |
11 |
Material Type: Article
|
![]() |
Percutaneous coronary intervention for non-obstructive vulnerable plaquesThe Lancet (British edition), 2024-05, Vol.403 (10438), p.1724-1725 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00488-4 ;PMID: 38604207Full text available |
12 |
Material Type: Article
|
![]() |
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' replyThe Lancet (British edition), 2024-05, Vol.403 (10438), p.1752-1752 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00353-2 ;PMID: 38704171Full text available |
13 |
Material Type: Article
|
![]() |
Housing: an overlooked social determinant of healthThe Lancet (British edition), 2024-05, Vol.403 (10438), p.1723-1723 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00914-0 ;PMID: 38704156Full text available |
14 |
Material Type: Article
|
![]() |
Rates and causes of death after release from incarceration among 1 471 526 people in eight high-income and middle-income countries: an individual participant data meta-analysisThe Lancet (British edition), 2024-05, Vol.403 (10438), p.1779-1788 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00344-1 ;PMID: 38614112Full text available |
15 |
Material Type: Article
|
![]() |
10 years on: the legacy of the Flint water crisisThe Lancet (British edition), 2024-04, Vol.403 (10437), p.1619-1620 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00860-2 ;PMID: 38679025Full text available |
16 |
Material Type: Article
|
![]() |
The future of valvular heart disease assessment and therapyThe Lancet (British edition), 2024-04, Vol.403 (10436), p.1590-1602 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02754-X ;PMID: 38554727Full text available |
17 |
Material Type: Article
|
![]() |
Heart valve disease: at the threshold of a new era in patient managementThe Lancet (British edition), 2024-04, Vol.403 (10436), p.1519-1522 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00423-9 ;PMID: 38554723Full text available |
18 |
Material Type: Article
|
![]() |
Coronary sinus reducer: a new hope for refractory angina?The Lancet (British edition), 2024-04, Vol.403 (10436), p.1514-1515 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00474-4 ;PMID: 38604208Full text available |
19 |
Material Type: Article
|
![]() |
Valvular heart disease: from mechanisms to managementThe Lancet (British edition), 2024-04, Vol.403 (10436), p.1576-1589 [Peer Reviewed Journal]2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02755-1 ;PMID: 38554728Full text available |
20 |
Material Type: Article
|
![]() |
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialThe Lancet (British edition), 2024-04, Vol.403 (10436), p.1543-1553 [Peer Reviewed Journal]2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00256-3 ;PMID: 38604209Full text available |